Daniela capitalizes on 20 years of international experience in pharmaceutical and biotech companies, academic institutions, and consulting organizations to help 3D clients succeed. Her track record, broad network of thought-leaders in the field, and thoughtful ability to bring innovation into the drug development process have earned her a reputation as a strategic advisor.
Daniela blends the pragmatism and creativity of her Italian upbringing with the structure and reliability of her Swiss training. Her hands-on style helps clients anticipate, understand, and address the strengths and weaknesses in their data to achieve their objectives.
Daniela has held senior global regulatory and medical affairs positions at companies ranging in size from start-ups to Fortune 500, including Biogen, Roche, and Bausch & Lomb. She has significant expertise across different modalities and in multiple rare and common therapeutic areas, including ophthalmology, neurology, and oncology. Daniela also served as an Associate Professor at George Washington University's School of Medicine, where she directed the regulatory as well as the clinical and translational research programs. Her published work includes more than 40 articles and book chapters. Daniela has been recognized as a Fellow of the Regulatory Affairs Professional Society (FRAPS) and the Organization for Professionals in Regulatory Affairs (FTOPRA). She received her Ph.D. in Chemistry from the Swiss Federal Institute of Technology (ETH Zurich).
Daniela supports organizations promoting women's and girls' health, education, and social services. She enjoys traveling, ethnic food, and playing tennis. Daniela was born on the Mediterranean coast and learned how to swim before she could walk, but her winter enthusiast and ski-loving husband and son take her to the slopes more often than to the beach.